BeOne Medicines Ltd
39 hedge funds and large institutions have $313M invested in BeOne Medicines Ltd in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 9 closing their positions.
30% more capital invested
Capital invested by funds: $241M → $313M (+$71.8M)
0% more funds holding
Funds holding: 39 → 39 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.8M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$6.93M |
| 4 |
PA
Perceptive Advisors
New York
|
+$3.83M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$5.16M |
| 2 |
ICP
Indus Capital Partners
New York
|
-$3.12M |
| 3 |
Millennium Management
New York
|
-$616K |
| 4 |
O
OrbiMed
New York
|
-$385K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$346K |
ONC Hedge Fund Activity: Q3 2016 in Review
39 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2016, worth a combined $313M — up 30% from $241M a quarter earlier.
Fund positioning in ONC was balanced in Q3 2016: 9 funds opened new positions, 9 closed out, 7 added to existing stakes and 8 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $28.6M. The largest seller was TD Asset Management, cutting an estimated $5.16M.
- 39 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $313M of BeOne Medicines Ltd stock for Q3 2016, up 30% quarter-over-quarter.
- 9 funds opened new BeOne Medicines Ltd positions in Q3 2016 and 9 closed out, a net change of 0 holders.
- The largest BeOne Medicines Ltd buyer in Q3 2016 was Fidelity Investments, an estimated $28.6M added.
- The largest BeOne Medicines Ltd seller in Q3 2016 was TD Asset Management, an estimated $5.16M sold.
Based on aggregated 13F filings for Q3 2016.